Breaking News, Collaborations & Alliances

ST Pharm, Quantoom Partner to Accelerate RNA Vaccine and Therapeutic Development

Aim to improve the global supply of critical RNA manufacturing technologies.

Author Image

By: Charlie Sternberg

Associate Editor

ST Pharm, a technology-driven RNA CDMO, and Quantoom Biosciences, a specialized RNA technology platform developer, have teamed up to accelerate the development and manufacturing of RNA-based vaccines and therapeutics.   This partnership combines their expertise to improve the global supply of critical RNA manufacturing technologies, with a first supply agreement of ST Pharm’s proprietary 5’-capping reagent, SmartCap.   By leveraging their respective strengths and expertise, ST Pharm and Quan...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters